Delic Holdings Corp.’s DELCF subsidiary Ketamine Wellness Centers will start offering a new therapy in some of its locations: NAD+ infusion therapy.
Starting on May 9, the clinics in Jacksonville, Houston, Salt Lake City, Dallas, Las Vegas and Tucson will introduce the new therapy to their offerings.
NAD+ is a fundamental coenzyme found in every cell of the body thought to have multiple beneficial effects, especially in maintaining cell health. The problem is that with age NAD+ levels naturally decrease.
Currently, there are numerous brands that sell the molecule as a supplement, such as Tru Niagen, Bulletproof, Theagehack and UltraNMN, but the offering for intravenous or intramuscular administration is much lower.
"The introduction of NAD+ infusion therapy to our clinics is a strong complement to ketamine therapy and has benefits for their mental and physical well-being,” commented Kevin Nicholson, CEO of Delic and KWC.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!